No marker to categorise the severity of chronic intestinal failure (CIF) has been developed. A 1-year international survey was carried out to investigate whether the European Society for Clinical Nutrition and Metabolism clinical classification of CIF, based on the type and volume of the intravenous supplementation (IVS), could be an indicator of CIF severity.
Pironi, L., Steiger, E., Joly, F., Wanten, G.J.A., Chambrier, C., Aimasso, U., et al. (2020). Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure. GUT, 69(10), 1787-1795 [10.1136/gutjnl-2018-318172].
Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure
Pironi, Loris
;Sasdelli, Anna Simona;Nardi, Elena;
2020
Abstract
No marker to categorise the severity of chronic intestinal failure (CIF) has been developed. A 1-year international survey was carried out to investigate whether the European Society for Clinical Nutrition and Metabolism clinical classification of CIF, based on the type and volume of the intravenous supplementation (IVS), could be an indicator of CIF severity.| File | Dimensione | Formato | |
|---|---|---|---|
|
Pironi et al-2020.pdf
accesso aperto
Tipo:
Postprint
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione
1.08 MB
Formato
Adobe PDF
|
1.08 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
